DURECT's CMO Dr Joseph Stauffer resigns
This article was originally published in Scrip
Executive Summary
Dr Joseph Stauffer, DURECT Corporation's chief medical officer and executive vice-president of corporate strategy, has resigned effective 21 June 2011. Dr Stauffer will continue as a consultant to DURECT, a specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, at least until 31 December 2011.